Adverum Biotechnologies, Inc. (ADVM)

4.36 0.00 (0.00%) USD  |  NASDAQ  |  Dec 23, 16:00
More

Adverum Biotechnologies SG&A Expense (TTM): 59.84M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ADVM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Eli Lilly & Co. 10.39B
Pfizer Inc. 13.91B
Recursion Pharmaceuticals, Inc. 220.12M
Quantum-Si, Inc. 48.78M
X4 Pharmaceuticals, Inc. 51.28M